Cambridge UK: 18 August 2026
J A Kemp is one of Europe’s leading filers of patent applications relating to cell and gene therapies. In this webinar, partners Lucy Barnes and Lucy Williams will draw on their extensive experience in this field to explore strategies for securing effective patent protection for cell and gene therapies.
They will consider how patent strategy can support investment and licensing, strengthen competitive position, and help build commercially valuable protection around both therapeutic products and platform technologies.
Welcome to the Q3 Edition of Our People Pathways Newsletter!
This edition brings together the latest opportunities, support and resources from across the One Nucleus network. From upcoming courses, seminars and webinars to mentoring opportunities, career support and our new Job Seeker Membership, there’s plenty to explore. We’ve also included useful connections, industry resources and updates to help you keep learning, build your network and stay connected to the life science community.
This webinar will discuss how AI and machine learning inventions fit into the framework for computer-implemented inventions at the EPO. We will provide insights and practical advice for how to identify potentially patentable aspects of AI inventions and how to obtain robust and commercially valuable protection for those inventions in Europe.
Topics covered include:
PMC are a specialist medical affairs consultancy working with pharmaceutical companies, generic manufacturers, and emerging biotechnology firms. We help life sciences organisations build, scale, and manage compliant medical affairs functions, covering regulatory strategy, medical copy review, interim medical leadership, and complete department build-outs.
Marketing and business development are treated as a single function here. Content and outreach only work when they are aligned, and one person owning both keeps the message consistent.
Clinical cytogenetics laboratories in the EU and other IVDR-aligned markets are under increasing pressure to maintain compliant, validated workflows while managing the practical impact of their portfolio transition. OGT’s IVDR programme is designed to help customers maintain continuity across the CytoCell portfolio, backed by a dedicated team of clinical and technical FISH specialists.
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions.
*Guest blog by Eramol. If you would like to submit a guest blog please email [email protected].
Written by David Cox, Site Director at Eramol
*Guest blog by Eramol. If you would like to submit a guest blog please email [email protected].
Early-phase clinical programmes often face a different set of challenges compared with late-stage or commercial manufacturing.
Take the next step in your scientific career with a growing specialist CRO.
Continued demand from new and existing clients is driving further growth in our business, so we’re looking for even more talented scientists to join our team.
We currently have a number of opportunities for Scientists – Ion Channel Screening and Research Associates who want to develop their careers in a specialist CRO environment.
Why consider a career with Metrion?